ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

NIH Biennial Report Offers Research Portrait

September 24, 2010

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Judge Rules FDA Can’t Enforce Pediatric Rule

October 25, 2002

Jury Awards $14 Million To Medenica Patient

February 24, 1995

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012